Molecular Infusions has a total of 22 patents globally, out of which no patents have been granted. Of these 22 patents, more than 22% patents are active. United States of America is where Molecular Infusions has filed the maximum number of patents, followed by Canada and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Molecular Infusions.
Molecular Infusions was founded in the year 2016. The Company is a patient-focused biopharmaceutical company committed to improving lives through advancing cannabis therapies.
Do read about some of the most popular patents of Molecular Infusions which have been covered by us in this article and also you can find Molecular Infusions patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Molecular Infusions patent portfolio.
How many patents does Molecular Infusions have?
Molecular Infusions has a total of 22 patents globally. These patents belong to 6 unique patent families. Out of 22 patents, 5 patents are active.
How Many Patents did Molecular Infusions File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Molecular Infusions Applications Filed | Molecular Infusions Patents Granted |
| 2022 | 1 | – |
| 2021 | 2 | – |
| 2020 | 4 | – |
| 2019 | 7 | – |
| 2018 | 8 | – |
How many Molecular Infusions patents are Alive/Dead?
How Many Patents did Molecular Infusions File in Different Countries?
Countries in which Molecular Infusions Filed Patents
| Country | Patents |
| United States Of America | 5 |
| Canada | 2 |
| Europe | 2 |
| Mexico | 1 |
| Colombia | 1 |
| China | 1 |
| Israel | 1 |
| Australia | 1 |
| Japan | 1 |
Where are Research Centres of Molecular Infusions Patents Located?
The Research Centre for all the Molecular Infusions patents is the United States of America.
10 Best Molecular Infusions Patents
US20200037638A1 is the most popular patent in the Molecular Infusions portfolio. It has received 24 citations so far from companies like Tilray, Disruption Labs and Nulixir.
Below is the list of 10 most cited patents of Molecular Infusions:
| Publication Number | Citation Count |
| US20200037638A1 | 24 |
| US20200246404A1 | 14 |
| CN110636834A | 11 |
| US20200138072A1 | 6 |
| JP2020509081A | 6 |
| US20200253922A1 | 4 |
| US20210299081A1 | 3 |
| WO2021195173A1 | 3 |
| CA3053158A1 | 2 |
| WO2020092987A1 | 2 |
What Percentage of Molecular Infusions US Patent Applications were Granted?
Molecular Infusions (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.
Below are the key stats of Molecular Infusions patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Molecular Infusions?
| Law Firm | Total Applications | Success Rate |
| Elmore Patent Law Group Pc | 5 | 0.00% |
List of Molecular Infusions Patents
| Molecular Infusions Patents | Title |
| EP3582755A4 | Formulations |
| CA3117809A1 | Polymer-Based Oral Cannabinoid And/Or Terpene Formulations |
| CA3053158A1 | Formulations |
| MX2019009642A | Formulations. |
| IL268697A | Formulations |
| US20210299081A1 | Solid Cannabinoid Formulation For Oral Administration |
| US20200253922A1 | Methods For Non-Irritating Pulmonary Administration Of Cannabinoids Using Soft Mist Inhalers |
| US20200246404A1 | Formulations |
| US20200138072A1 | Polymer-Based Oral Cannabinoid And/Or Terpene Formulations |
| US20200037638A1 | Formulations |
| EP3873440A4 | Polymer-Based Oral Cannabinoid And/Or Terpene Formulations |
| CN110636834A | Formulations |
| WO2022182844A1 | Purified Cannabinodis Isolated From Fermentate |
| WO2021195173A1 | Solid Cannabinoid Formulation For Oral Administration |
| WO2020167893A1 | Methods For Non-Irritating Pulmonary Administration Of Cannabinoids Using Soft Mist Inhalers |
| WO2020167892A1 | Methods For Non-Irritating Pulmonary Administration Of Cannabinoids Using Soft Mist Inhalers |
| WO2020092987A1 | Polymer-Based Oral Cannabinoid And/Or Terpene Formulations |
| WO2019036243A1 | Formulations |
| WO2018152334A1 | Formulations |
| JP2020509081A | Pharmaceutical Formulation |
| CO20190009986A2 | Formulations |
| AU2018221739A1 | Formulations |
What are Molecular Infusions key innovation segments?
What Technologies are Covered by Molecular Infusions?
The chart below distributes patents filed by Molecular Infusions